FineHeart Receives ANSM1 Authorization to Deploy Its First-In-Human Clinical Study in France

Patients with advanced heart failure will be treated with FlowMaker®, an innovative, fully implantable device for restoring cardiac output. BORDEAUX, France–(BUSINESS WIRE)–FineHeart S.A., a clinical-stage medical technology company specializing in the development of innovative solutions for cardiology, announces that it has received authorization from the French National Agency for the Safety of Medicines and Health … [Read more…]

Leyden Labs Lands €20 Million EIB Investment Facilitated by HERA to Advance Pandemic Preparedness Activities

European Investment Bank and Leyden Labs sign €20 million financing to advance Leyden Labs’ pandemic preparedness activities, guaranteed by European Commission’s InvestEU initiative through its Health Emergency Preparedness and Response (HERA). Funding is part of “HERA Invest,” a €110 million top-up to the European Union’s InvestEU initiative, meant to address pandemic readiness, biodefense and antimicrobial … [Read more…]

Calm Health Expands Globally, Starting with UK and Canada

Building on U.S. success, Calm Health launches internationally to help bridge care gaps, increase engagement with employer and health benefits, and scale access to mental health resources. PALO ALTO, Calif.–(BUSINESS WIRE)–Calm, a leading mental health company, today announced the international expansion of Calm Health, its evidence-based app that provides consumers access to mental health support … [Read more…]

RGA Announces 150 Billion JPY Coinsurance Transaction with The Dai-ichi Life Insurance Company

TOKYO–(BUSINESS WIRE)–Reinsurance Group of America, Incorporated (NYSE: RGA), a leading global life and health reinsurer, today announced that it reached an agreement with The Dai-ichi Life Insurance Company, Limited (Dai-ichi) for an RGA subsidiary to reinsure 150 billion JPY of statutory reserves through coinsurance. “Building on our successful collaboration with Dai-ichi since 2020, we are … [Read more…]

Align Technology Awards Funding to Universities Worldwide for Advancing Orthodontic and Dental Research

$300,000 in Research Grants Awarded as Part of its Ongoing Annual Research Awards Program TEMPE, Ariz.–(BUSINESS WIRE)–Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the … [Read more…]

MaaT Pharma Advances Toward Commercialization And Submits Marketing Authorization Application to the European Medicines Agency (EMA) for Xervyteg® (MaaT013) in Acute Graft-versus-Host Disease

MaaT Pharma submitted today a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for its product candidate MaaT013, under the registered brand name of Xervyteg®. Xervyteg® has the potential if approved, to become the first microbiota therapeutic approved by the EMA and the first one in hemato-oncology globally. The MAA submitted to the … [Read more…]

Fi Unleashes the World’s First AI-Powered Smart Dog Collar, Built for Real-Time Health and Behavior Detection

Combining best-in-class GPS tracking with a comprehensive suite of AI-powered health and behavior detection, Series 3+ sets a new standard for connected dog care, paving the way for the future. NEW YORK–(BUSINESS WIRE)–Fi, the leader in smart pet technology, today announced the launch of its newest product: Fi Series 3+, the world’s first AI-powered collar … [Read more…]

SCIEX Sets a New Standard in Accurate Mass Quantitation With the ZenoTOF 8600 System and New Software Collaborations

MARLBOROUGH, Mass.–(BUSINESS WIRE)–#ZenoTOF–At ASMS 2025, SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation (NYSE: DHR), launches the ZenoTOF 8600 system, setting a new standard in accurate mass quantitation. The system is competitive in identification, superior in quantitation, and enhances structural understanding so scientists can now confidently quantify thousands … [Read more…]

Latest Data of InnoCare’s Robust Oncology Pipelines Presented at the 2025 ASCO Annual Meeting

BEIJING–(BUSINESS WIRE)–#InnoCare–Latest data of InnoCare’s robust oncology pipelines were presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, involving the anti-CCR8 antibody ICP-B05 (CM369), the BCL2 inhibitor mesutoclax (ICP-248) and the pan-TRK inhibitor zurletrectinib (ICP-723). Oral Presentation Title: Preliminary results from the dose-escalation stage of a phase I trial of an anti-CCR8 … [Read more…]

Hyundai Card Becomes First in Asia to Achieve UL Solutions Healthy Building Verifications for Cultural and Leisure Facilities

Four iconic Hyundai Card structures earn the UL Verified Healthy Building Mark, demonstrating Hyundai Card’s commitment to creating healthier and more sustainable indoor environments for employees and guests. NORTHBROOK, Ill.–(BUSINESS WIRE)–UL Solutions (NYSE: ULS), a global leader in applied safety science, today announced that four properties operated by Hyundai Card, a leading South Korean credit … [Read more…]